ACPH.BR

Acacia Pharma Group plc [ACPH.BR] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

ACPH.BR Stock Summary

In the News

ACPH.BR Financial details

Company Rating
Neutral
Market Cap
0
Income
-17.07M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
76
Optionable
No
Shortable
Yes
Earnings
31 Mar 2022
P/E
-1.16
Forward P/E
-
PEG
0.17
P/S
-
P/B
3
P/C
-
P/FCF
-
Quick Ratio
2.62
Current Ratio
3.79
Debt / Equity
1.08
LT Debt / Equity
1.08
-
-
EPS (TTM)
-0.19
EPS next Y
-
EPS next Q
-
EPS this Y
35.48%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
19.68%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-108%
ROE
-155%
ROC
-1.2%
Gross Margin
75%
Oper. Margin
-5561%
Profit Margin
-5767%
Payout
-
Shs Outstand
100.94M
Shs Float
51.23M
-
-
-
-
Target Price
-
52W Range
0.876-0.89
52W High
-
52W Low
-
RSI
-
Rel Volume
1.89
Avg Volume
402.31K
Volume
761.38K
Perf Week
0%
Perf Month
-
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
1.78911
-
-
Volatility
0%, 0%
Prev Close
0%
Price
0.888
Change
-

ACPH.BR Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000.01
Net income per share
-0.16-0.45-0.43-0.62-0.84
Operating cash flow per share
-0.1-0.34-0.37-0.47-0.56
Free cash flow per share
-0.1-0.34-0.37-0.47-0.56
Cash per share
0.080.840.320.870.27
Book value per share
-0.450.560.081.130.32
Tangible book value per share
-0.450.560.080.15-0.06
Share holders equity per share
-0.450.560.081.130.32
Interest debt per share
0.270.260.210.720.39
Market cap
41.78M35.29M40.72M43.01M59.47M
Enterprise value
50.09M7.31M33.59M32.82M65.88M
P/E ratio
-5.01-1.79-1.78-1.28-0.89
Price to sales ratio
000203.8651.14
POCF ratio
-8.25-2.39-2.05-1.7-1.33
PFCF ratio
-8.25-2.39-2.05-1.7-1.33
P/B Ratio
-1.741.449.370.712.3
PTB ratio
-1.741.449.370.712.3
EV to sales
000155.5756.65
Enterprise value over EBITDA
-7.39-0.4-1.53-1.14-1.17
EV to operating cash flow
-9.89-0.49-1.69-1.29-1.48
EV to free cash flow
-9.89-0.49-1.69-1.29-1.48
Earnings yield
-0.2-0.56-0.56-0.78-1.13
Free cash flow yield
-0.12-0.42-0.49-0.59-0.75
Debt to equity
-0.520.382.270.61.08
Debt to assets
2.580.240.530.350.45
Net debt to EBITDA
-1.231.540.330.35-0.11
Current ratio
0.177.481.94.553.79
Interest coverage
-2-8.08-15.05-14.12-19.38
Income quality
0.610.750.870.760.66
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00054.8215.5
Research and developement to revenue
0000.473.5
Intangibles to total assets
0000.510.49
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00012.773.29
Graham number
1.272.360.883.982.47
ROIC
0.33-0.54-1.49-0.31-1.18
Return on tangible assets
-1.73-0.51-1.22-0.66-2.14
Graham Net
-0.470.530.050.11-0.14
Working capital
-24.03M33.36M8.68M39.32M22.98M
Tangible asset value
-24.03M24.52M4.35M8.32M-4.74M
Net current asset value
-24.03M24.52M3.98M8.04M-4.92M
Invested capital
-0.520.382.270.61.08
Average receivables
00000
Average payables
3.85M1.24M1.89M1.9M1.95M
Average inventory
0001.33M4.77M
Days sales outstanding
00000
Days payables outstanding
00014.4K3.41K
Days of inventory on hand
00033.5K8.5K
Receivables turnover
00000
Payables turnover
0000.030.11
Inventory turnover
0000.010.04
ROE
0.35-0.8-5.25-0.55-2.59
Capex per share
00000

Quarterly Fundamentals Overview

Last date of statement is 2021-12-31 for Q4

Metric History 2019-12-312020-06-302020-12-312021-06-30 2021-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
00000
Operating cash flow per share
00000
Free cash flow per share
00000
Cash per share
00000
Book value per share
00000
Tangible book value per share
00000
Share holders equity per share
00000
Interest debt per share
00000
Market cap
00000
Enterprise value
-7.13M-16.71M-10.19M-17.55M6.41M
P/E ratio
00000
Price to sales ratio
00000
POCF ratio
00000
PFCF ratio
00000
P/B Ratio
00000
PTB ratio
00000
EV to sales
00000
Enterprise value over EBITDA
00000
EV to operating cash flow
00000
EV to free cash flow
00000
Earnings yield
00000
Free cash flow yield
00000
Debt to equity
2.270.310.60.451.08
Debt to assets
0.530.210.350.290.45
Net debt to EBITDA
00000
Current ratio
1.92.974.557.133.79
Interest coverage
00000
Income quality
00000
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00.30.5100.49
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
00000
ROIC
00000
Return on tangible assets
00000
Graham Net
00000
Working capital
8.68M16.94M39.32M46M22.98M
Tangible asset value
4.35M14.54M8.32M65.57M-4.74M
Net current asset value
3.98M14.22M8.04M16.54M-4.92M
Invested capital
2.270.310.60.451.08
Average receivables
00000
Average payables
00000
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
00000
Capex per share
00000

ACPH.BR Frequently Asked Questions

What is Acacia Pharma Group plc stock symbol ?

Acacia Pharma Group plc is a GB stock , located in Cambridge of Cambridgeshire and trading under the symbol ACPH.BR

What is Acacia Pharma Group plc stock quote today ?

Acacia Pharma Group plc stock price is $0.888 today.

Is Acacia Pharma Group plc stock public?

Yes, Acacia Pharma Group plc is a publicly traded company.

Something similar

Top by Market Cap
Similar Market Cap